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The membrane-associated, processive and retaining glycosyltransferase PglH from Campy-
lobacter jejuni is part of the biosynthetic pathway of the lipid-linked oligosaccharide (LLO) that
serves as the glycan donor in bacterial protein N-glycosylation. Using an unknown counting
mechanism, PglH catalyzes the transfer of exactly three α1,4 N-acetylgalactosamine (Gal-
NAc) units to the growing LLO precursor, GalNAc-α1,4-GalNAc-α1,3-Bac-α1-PP-undecapre-
nyl. Here, we present crystal structures of PglH in three distinct states, including a binary
complex with UDP-GalNAc and two ternary complexes containing a chemo-enzymatically
generated LLO analog and either UDP or synthetic, nonhydrolyzable UDP-CH2-GalNAc. PglH
contains an amphipathic helix (“ruler helix”) that has a dual role of facilitating membrane
attachment and glycan counting. The ruler helix contains three positively charged side chains
that can bind the pyrophosphate group of the LLO substrate and thus limit the addition of
GalNAc units to three. These results, combined with molecular dynamics simulations, provide
the mechanism of glycan counting by PglH.
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Protein N-glycosylation requires a lipid-linked oligo-saccharide (LLO) that acts as a glycan donor of the transferreaction. In the Gram-negative bacterium Campylobacter
jejuni, the relevant LLO is synthesized in the cytoplasmic side of
the plasma membrane, in a process that involves several glyco-
syltransferases that use uridine diphosphate (UDP)-activated
sugars as substrates1, 2 (Supplementary Fig. 1). The ﬁrst step of
LLO biosynthesis is the conversion of UDP-GlcNAc to UDP-N,
N’-2,4-diacetylbacillosamine (UDP-Bac) by the enzymes PglF,
PglE, and PglD2, 3. Bac-phosphate is then transferred to the lipid
carrier undecaprenyl phosphate (Und-P) by PglC, yielding Und-
PP-Bac4, 5. Subsequently, ﬁve terminal N-acetylgalactosamine
(GalNAc) units are transferred by the enzymes PglA, PglJ, and
PglH. Whereas PglA and PglJ each catalyzes a single GalNAc
transfer reaction6 (yielding α-1,3 and α-1,4 linkages, respectively),
PglH catalyzes the addition of three α-1,4 GalNAc units2, 7
(Fig. 1a). As a ﬁnal step, PglI adds a glucose moiety, which leads
to a branched β-1,3-linkage. The mature LLO is subsequently
ﬂipped to the periplasm by the ATP-binding cassette transporter
PglK8 and used by the single-subunit oligosaccharyltransferase
PglB9 for glycan transfer onto acceptor proteins.
Among the various glycosyltransferases (GTs) involved in this
process, PglH stands out because it is a membrane-associated
enzyme that catalyzes a well-controlled, processive reaction2, 7.
However, in the absence of a high-resolution structure, it is not
known how this B-family GT achieves its highly precise glycan
length control. There are several other processive, length-
controlling GTs involved in biological processes: For example,
Alg11 catalyzes the addition of two α1,2-linked mannoses to Dol-
PP-GlcNAc2Man3, during the biosynthesis of the eukaryotic
LLO10. Another example is the mycobacterial galactofuranosyl
transferase 1 (Glft1) that is involved in the biosynthesis of ara-
binogalactan11. To understand the structural basis of such a
counting mechanism, we combine structural studies and mole-
cular dynamics simulations with synthetic, chemo-enzymatic, and
enzymological studies, and uncover a mechanism by which PglH
controls the number of successive glycan transfer reactions using
a structural element that not only attaches the protein to the
membrane surface, but also contains residues that interact with
the pyrophosphate group of the LLO during elongation of the
glycan moiety.
Results
Functional analysis and inhibitor trapping of PglH. Although
C. jejuni PglH is not an integral membrane protein, non-ionic
detergents (Triton X-100 and dodecyl maltoside) were required
for its successful puriﬁcation in homogeneous and active form
(Supplementary Fig. 2). Whereas the donor substrate UDP-
GalNAc is commercially available, the LLO substrate (acceptor) is
not. We therefore pursued a dual approach: for in vitro assays, the
tri-saccharide-containing LLO Und-PP-Bac-GalNAc2 (Tri-LLO)
was extracted and partially puriﬁed from Escherichia coli cells
expressing the C. jejuni pgl operon but containing inactivated
pglB and pglH genes12. It was then incubated with puriﬁed PglH
and UDP-GalNAc. The resulting LLO products were then used as
donor substrates and their glycan moieties transferred onto a
ﬂuorescently labeled peptide using the puriﬁed bacterial oligo-
saccharyltransferase PglB, followed by tricine sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE)
analysis13, 14 (Fig. 1b). While transfer of three GalNAc residues
was very efﬁciently completed, we observed that PglH could add
more than three GalNAc units to the LLO when the reaction was
incubated for 16 h (Fig. 1b). Turnover rates of the PglH-catalyzed
reaction could be determined by quantitating the amount of Und-
PP-Bac-GalNAc5 (Hexa-LLO) produced.
Even though Und-PP-Bac-GalNAc2 could be efﬁciently
extracted and used for in vitro activity assays, it requires 1%
Triton X-100 for its solubilization and could only be concentrated
to ~300 µM, making it impractical for co-crystallization experi-
ments. We therefore devised a chemo-enzymatic approach
starting from synthetic NerylNeryl-PP-GlcNAc15, 16, which was
extended to a tri-saccharide-containing LLO analog using
recombinantly expressed and puriﬁed PglA and PglJ proteins3
(Fig. 1c). Despite the fact that GlcNAc rather than N,N’-
diacetilbacillosamine was present as the reducing-end sugars, all
Pgl enzymes accepted the LLO analog as a substrate. The
products of the PglA- and PglJ-catalyzed reactions were analyzed
by Tricine SDS-PAGE after the glycans were transferred onto
ﬂuorescently labeled peptides using PglB16 (Supplementary
Fig. 3). The chemo-enzymatically generated trisaccharide-LLO
analog was accepted as a substrate by PglH, but the turnover rate
was 50-fold lower than that of the Und-containing LLO substrate.
In order to trap PglH in an intermediate state that could mimic
the transition state of the reaction catalyzed, we synthesized the
compound UDP-CH2-GalNAc, which carries a phosphonate
group at the anomeric carbon and is thus nonhydrolyzable
(Supplementary Fig. 4). This compound could indeed inhibit
PglH (half-maximal inhibitory concentration (IC50) of 303± 24
µM) and exhibited a slightly higher afﬁnity for PglH than UDP
(IC50 of 1023± 87 µM, Fig. 1d). Both the phosphonate compound
and UDP could be used to trap ternary complexes.
Architecture of PglH and donor substrate binding. We deter-
mined the structure of PglH in three distinct states. The structure
of a binary complex with the donor substrate UDP-GalNAc was
determined at 2.3 Å resolution, whereas the structures of ternary
complexes including synthetic acceptor LLO and either UDP or
UDP-CH2-GalNAc were determined at 2.8 Å and 3.3 Å, respec-
tively. Crystallographic data and reﬁnement statistics are pre-
sented in Supplementary Table 1. PglH exhibits the protein fold
described for GT-B GTs, consisting of two Rossman-like domains
connected by a linker region (Fig. 2a, Supplementary Fig. 5). The
conformation of PglH is similar in all three structures, although a
slight rotation of the C-terminal vs. the N-terminal domain is
observed in the ternary complex, where PglH is bound to UDP
and LLO analogs. The electrostatic surface potential of PglH
shows that the alpha helix α2 is strongly amphipathic, con-
tributing to the formation of a positive charged cluster and to a
hydrophobic surface patch (Fig. 2b). Whereas similar helices were
observed in other membrane-associated GTs such as the phos-
phatidyl mannosyltransferase PimA17–19, α2 is considerably
longer in PglH than in other GT-B family members of known
structure (Supplementary Fig. 6). This helix is termed “ruler helix”
because it acts as a molecular ruler (see below).
The structure of PglH bound to UDP-GalNAc revealed the
molecular details of the interactions with the donor substrate. The
uridine moiety is positioned in a pocket formed by α12 and the
loop connecting α10 and α11. There are two hydrogen bonds of
the uracil moiety with the main chain of V247. The 2’ and 3’
hydroxyl groups of the ribose moiety form hydrogen bonds with
E275, which is part of the conserved EX7E motif along with E267,
which interacts with the N-acetyl group of GalNAc (Fig. 3a).
When we individually mutated E267 and E275 to alanine, we
observed an ~300-fold decrease in the turnover rate of PglH
compared to wild type (Table 1), in agreement with earlier
observations7. The pyrophosphate moiety interacts via hydrogen
bonds with R191, K196, and T271 (Fig. 3a). R191 and K196 are
conserved in the GT-B family and were proposed to stabilize the
leaving group (UDP) following the transfer reaction20. In the
structures with LLO bound, R191 also interacts with the N-acetyl
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group of the acceptor GalNAc (Fig. 3a, b). Individual mutations
of R191 or K196 to alanine led to a complete loss of the activity,
whereas the mutant T271A exhibited only a ﬁvefold reduction in
turnover rate compared to wild type (Table 1), suggesting that
this side chain is involved in phosphate binding but does not have
a catalytic role unlike R191 and K196.
The GalNAc unit is located in the cleft formed between the N-
and C-terminal domains. Unlike in some structural studies of
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Fig. 1 In vitro activity. a Reaction catalyzed by PglH during bacterial LLO biosynthesis. b Schematic representation of the in vitro assay used to quantitate
PglH activity, with symbol legend at the bottom left of the panel. In a ﬁrst step, tri-LLO is elongated by PglH. In a second step, the resulting glycan is
transferred to a ﬂuorescently labeled acceptor peptide using puriﬁed PglB protein. Green stars represent carboxyﬂuorescein attached to the N terminus of
the synthetic peptide. c Schematic representation of the chemo-enzymatic generation GalNAc-α1-4-GalNAc-α1-4-GlcNAc-α1-PP-NerylNeryl, using puriﬁed
PglA and PglJ proteins, with symbol legend at the bottom left of the panel. d PglH activity was measured in the presence of different concentrations of
reaction inhibitors UDP or UDP-CH2-GalNAc. Relative inhibition values were calculated, allowing IC50 determination. Data points reﬂect the mean of three
separate measurements, error bars indicate s.d.
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GT-B enzymes19, 21, 22, the saccharide moieties were clearly
visible not only for the non-hydrolyzable UDP-CH2-GalNAc, but
also for the functional UDP-GalNAc (Supplementary Fig. 7). The
6’ hydroxyl of GalNAc forms a hydrogen bond with the side
chain of H118 (Fig. 3a). Mutation of H118 to alanine led to a
decrease of about 10-fold in the turnover rate (Table 1),
supporting the stabilizing role of this interaction, which was also
observed in the structures of other retaining GTs including
MalP23 and OtsA24. The structure can explain the speciﬁcity of
PglH for GalNAc over GlcNAc: whereas the axial hydroxyl group
at C4 of GalNAc can be accommodated by the enzyme, an
equatorial hydroxyl group (present in GlcNAc) would generate a
steric clash with the main chain carbonyl oxygen of L269
(Supplementary Fig. 8). The neighboring residue P270 may
contribute to the rigidity of this region and therefore help in
preventing the binding of UDP-GlcNAc. We observed that PglH
did not accept UDP-GlcNAc as a substrate even after overnight
incubation of the reaction mix, whereas the reaction with UDP-
GalNAc under the same conditions was complete after 20 min
(Supplementary Fig. 8).
LLO binding site and geometry of the active site. In both
ternary complex structures, we could observe density for the
three saccharides and the pyrophosphate group of the LLO
analog, whereas the lipid tail was disordered (Supplementary
Fig. 7). The LLO binding site is formed by the N-terminal
domain of PglH and reaches from the catalytic pocket to the
ruler helix α2. While there are distinct interactions with the
terminal GalNAc residue, PglH provides only limited contacts to
the reducing-end GlcNAc and the central GalNAc, in agreement
with the ﬁnding that there is no strict requirement for a bacil-
losamine at the reducing-end position. The structure of PglH
bound to LLO and UDP-CH2-GalNAc visualizes an intermediate
before reaching the transition state, whereas that bound to UDP
can mimic a state after the transfer has been completed. In the
ternary complex with UDP-CH2-GalNAc, the GalNAc moiety is
in a “bent-back” conformation towards UDP, similar to what we
observed in the structure of the binary complex of PglH with
UDP-GalNAc and to what was observed in other GTs including
PimA25, MshA26, and HepE27. This conformation allows the C4
hydroxyl of the terminal GalNAc of the LLO to be positioned at a
distance of ~2.7 Å from the anomeric carbon of UDP-CH2-
GalNAc and ~3.4 Å from the methylene group mimicking O4 of
UDP-GalNAc. In addition, it formed a hydrogen bond with the
oxygen from the β-phosphate of the donor substrate analog
(Fig. 3b, c). The orientation of the terminal GalNAc of the LLO is
locked by two interactions of the C2-acetamido group with side
chains of R191 and E18 (Fig. 3b, c). Mutation of these two
residues to alanine abolished PglH activity (Table 1). However,
because R191 also interacts with the pyrophosphate group of the
leaving UDP, the R191A mutation has a dual effect. The absence
of a potential nucleophile at the β-face of the anomeric carbon of
UDP-CH2-GalNAc might suggest that PglH uses a SN1-like
mechanism. The lack of evidence of the formation of an inter-
mediate covalently bound to the enzyme was used to argue that
most retaining GT-B members do not use a double displacement
mechanism20, 28.
Counting mechanism. The ternary complex structures reveal
that the pyrophosphate group of the tri-LLO analog is appro-
priately positioned to form salt bridges with the positively
charged residues K75 and R72 located in the ruler helix, whose
side chains point towards the bound substrate (Fig. 4a). In
addition to K75 and R72, there is a third positively charged
residue in the ruler helix, K68, located one helix turn apart from
R72. Given that PglH processes LLOs with three, four, or ﬁve
saccharide moieties, we hypothesized that with every addition of a
GalNAc moiety, the pyrophosphate group gets pushed further
from the active site, successively interacting with K75, R72, and
K68. We therefore analyzed the effect of mutating these residues
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Fig. 2 Crystal structure of PglH. a Ribbon diagram of PglH in complex with synthetic LLO and UDP-CH2-GalNAc. N-terminal and C-terminal domains are
colored in light pink and light orange, respectively. The N-terminal domain of PglH (residues 1 to 168) contains a parallel, 7-stranded β-sheet connected by
six α-helices. The C-terminal domain (residues 185 to 357) contains a parallel, 5-stranded β-sheet connected by seven α-helices and a terminal α-helix that
folds back to the N-terminal domain. Alpha helix α2 (termed “ruler helix”) is shown in dark orange. Bound substrates are shown as spheres (green for UDP-
CH2-GalNAc, blue for LLO analog). b APBS-calculated electrostatic surface potential of PglH, color coded from blue (most positive) to red (most negative)
to white (uncharged). The orientation of the left panel is identical to that in a
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individually and in combination (Fig. 4b) by titrating the enzyme
concentration. Individual mutations of K75 and R72 to alanine
resulted in 10-fold and 6-fold reduction of the rate of hexa-LLO
generation, respectively, and the combination of the two muta-
tions led to a decrease in the turnover rate of about 50-fold
(Table 1). Simultaneous mutation of R72 and K68 to alanine led
to a 6.5-fold decrease in the turnover rate, whereas the simulta-
neous mutations of K75, R72, and K68 led to a 1000-fold decrease
in the turnover rate of PglH. Quantiﬁcation of the LLO inter-
mediates of the reaction using single mutations showed that in
the K75A mutant, an accumulation of the tri-LLO substrate
(Und-PP-BacGalNAc2) occurred (red bars in Suppl. Fig. 9, top
left panel). In contrast, the mutant R72A yielded a slight accu-
mulation of the tetra-LLO intermediate Und-PP-BacGalNAc3
(green bars in Suppl. Fig. 9, top right panel). The strongest effect
was observed for the mutant K68A, which resulted in a pro-
nounced accumulation of the penta-LLO intermediate Und-PP-
BacGalNAc4 (yellow bars in Supplementary Fig. 9, bottom left
panel). These ﬁndings are in line with a sequential interaction of
the pyrophosphate group of the acceptor LLO with the residues
K75, R72, and K68. When the activity measurements were per-
formed with tri-LLO substrate reconstituted in liposomes, we
found that the accumulation of intermediates was lower than in
detergent, suggesting that the lipidic environment or the longer
polyprenyl tail increase the processive characteristic of the reac-
tion (Supplementary Fig. 10). For the PglH variant K75A, the tri-
LLO substrate was accumulated as it was more slowly processed.
Once the ﬁrst GalNAc was added, the reaction of K75A pro-
ceeded quickly, as no other intermediates were observed. For
R72A, no clear pattern was observed. For K68, a band corre-
sponding to the penta-LLO intermediate was observed, albeit less
pronounced than in the detergent-based reaction. In combina-
tion, our results suggest that the three positive charges in helix α2
are key elements of a molecular ruler that directly links the
binding of the pyrophosphate group to successful binding of the
LLO molecule for further addition of a GalNAc moiety. Upon
addition of three GalNAc units, the pyrophosphate group would
be pushed beyond the location of the three positively charged
residues, resulting in decreased binding of the LLO substrate.
Association of PglH with the membrane and LLO recruitment.
Given the amphipathic nature of the ruler helix (Fig. 2b) and its
interaction with the pyrophosphate group of the LLO substrate,
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Fig. 3 Binding of substrates at the catalytic site. a Interactions of PglH with
the donor substrate UDP-GalNAc. Side chains of the C-terminal and N-
terminal domains are colored pink or orange, respectively, and labeled in
single-letter code. Black dashed lines indicate hydrogen bonds. b Stereo
view of the catalytic site of PglH bound to LLO analog and UDP-CH2-
GalNAc. Acceptor and donor substrates are shown as blue and green sticks
and labeled. PglH residues essential for function are shown as sticks and
labeled. Black, dashed lines represent interactions between PglH and bound
substrates. Red dashed lines indicate distances between the C4 hydroxyl of
the acceptor GalNAc and the anomeric carbon or the methylene group from
the phosphonate group. c Schematic of the interactions between PglH and
donor and acceptor substrates in the catalytic site. A red dashed line
indicates the distance between the C4 hydroxyl of the acceptor substrate
and the anomeric carbon of the donor substrate. Black dashed lines
represent interactions between PglH and the substrates. Green dashed lines
represent two possible, but mutually exclusive hydrogen bonds
Table 1 Turnover rates for PglH mutants
PglH Turnover rate (Hexa-LLO·PglH−1 s−1)
WT 2.00± 0.34
H118A 0.19± 0.03
T271A 0.34± 0.08
E267A 0.008± 0.001
E275A 0.006± 0.001
R191A No activitya
K196A No activitya
E18A No activitya
K75A 0.19± 0.01
R72A 0.31± 0.01
K68A 0.69± 0.04
K75A, R72A 0.039± 0.005
R72A, K68A 0.15± 0.07
K75A, R72A, K68A 0.002± 0.001
Activity measurements were performed as described in Fig. 1. Turnover rates represent the
average of 3 separate measurements± s.d.
aNo activity: turnover rate could not be calculated because no product could be detected or its
level was below the detection limit of the assay
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Fig. 4 Dual role of ruler helix α2 in PglH. a Ribbon diagram of PglH bound to LLO analog as observed in the ternary complex PglH—UDP—LLO. The LLO
analog and the three positively charged side chains of PglH interacting with the pyrophosphate group of the LLO are shown as sticks. Dashed lines depict
salt bridge/hydrogen bond interactions. b Activity of wild type and mutant PglH. The reactions were performed for 10 min, after which the reactions
stopped and the products were used as donor substrates for in vitro glycosylation of ﬂuorescently labeled peptide by PglB and analyzed by tricine SDS-
PAGE. The amount of enzyme varied and is indicated on top of the lanes. c Left, interaction of PglH with the modeled lipid bilayer. The electrostatic surface
of PglH is shown, and the position of the ruler helix is indicated by and arrow and labeled. Lipids are shown in surface representation. Right, the
hydrophobic groove generated in the membrane upon displacement of lipid head groups by PglH is shown by an arrow and labeled. d Interaction of PglH
with the membrane bilayer and with the native LLO substrate Und-PP-Bac-GalNAc2 as determined by molecular dynamics simulations. PglH is shown as a
ribbon, with bound UDP and LLO shown as sticks. Phospholipids are shown as thin lines. Coordinates of the glycan and pyrophosphate moieties of LLO
were from the ternary complex structure, whereas the polyprenyl tail was modeled. The inset shows a close-up of the interaction between the ruler helix
with the lipid bilayer and LLO. PglH residues contributing to the interactions with lipid head groups or tails are shown as sticks and labeled
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we hypothesized that it might interact with lipids and attach PglH
to the membrane surface. To probe this interaction, we per-
formed molecular dynamic simulations of PglH and a lipid
membrane in the absence or presence of the polyprenyl tail of the
native Und-PP-Bac-GalNAc2 substrate. In the absence of LLO,
PglH associated with the membrane in two similar orientations,
both of which involve the ruler helix as the key element in
membrane attachment, either by interaction of the positively
charged residues R61, K74, R80, K81, K84, and K87 with lipid
head groups (Supplementary Fig. 11a), or via hydrophobic
interactions with the residues L65, I69, F73, and F77 (Supple-
mentary Fig. 11b). Both orientations allow PglH to interact with
the LLO substrate.
In simulations performed with the ternary complex with UDP
and LLO, we found PglH to interact tightly with the lipid
membrane. In particular, the hydrophobic face of the ruler helix
was buried into the membrane and formed direct interactions
with the lipid tails. The head groups of these lipids were pushed to
the side, where they interacted with a series of basic residues
forming a ring (Fig. 4c). During the simulation, the glycan moiety
of the LLO was not as close to the active site as observed in the
crystal structures. However, three isoprenyl units of the LLO
interacted with F76 and F73 of the ruler helix (Fig. 4d). A
combination of hydrophobic and charge interactions of lipids
with the ruler helix and additional side chains of the N-terminal
domain thus stabilize PglH at the membrane, with its active site
accessible to membrane-anchored LLO.
Discussion
The structural characterization of membrane-associated GTs in
complex with substrates is particularly challenging if the sub-
strates are non-commercial and contain long lipidic tails that
limit water solubility. The chemo-enzymatic generation of tri-
LLO analogs combined with the synthesis of the non-
hydrolyzable phosphonate analog of UDP-GalNAc allowed for
the ﬁrst time the trapping and visualization of a transition-state
mimic of a membrane-associated GT-B. Similar analogs of
nucleotide-activated sugars had previously been used as inhibitors
of GTs or have been co-crystallized with GTs that exhibit gly-
cosidase activity29–32. However, ternary complexes containing
acceptor and donor substrate analogs have been only reported for
retaining GT-B members with soluble substrates such as MshA
(in complex with UDP and 1-L-myo-inositol-1-phosphate
bound)26, OtsA (in complex with Glc-6-P and UDP)33, and GtfA
(in complex with vancomycin and nucleotide diphosphate
bound)34.
Retaining GTs have been proposed to either follow a double
displacement mechanism, involving the formation of an inter-
mediate covalently bound to the enzyme, or a SNi-like mechan-
ism, which requires the formation of an oxocarbenium
intermediate20, 28, 35, 36. Similar to observations in the GT-B
members BshA37, MshA26, and OtsA24, 33, our PglH structure did
not reveal a nucleophile in the active site that would facilitate a
double displacement mechanism. Instead, PglH might indeed
follow a SN1-like mechanism, where the nucleophilic attack from
the acceptor substrate and the departure of the leaving UDP
occur from the same side. This would require the leaving group to
act as a catalytic base to activate the incoming nucleophile38.
Based on the modeling of a ternary complex followed by
quantum mechanics calculations, a mechanism for glucose transfer
from UDP-Glc to glucose-6-phosphate by the retaining GT OstA
was recently proposed39. In this study, a hydrogen bond between a
hydroxyl group of the acceptor substrate and one of the non-
bridging oxygen atoms of the pyrophosphate moiety of UDP was
postulated. In our PglH ternary complexes, we indeed observed
such a hydrogen bond between the C4 hydroxyl of the acceptor
GalNAc and UDP (Fig. 3b, c). For OstA, a second hydrogen bond
between the acceptor hydroxyl and the oxygen connecting the
anomeric carbon with the ﬁrst phosphate group was proposed to
stabilize the leaving UDP and subsequently enhance the nucleo-
philicity of the acceptor hydroxyl. Because we used a phosphonate
analog (Fig. 3b, c), we do not have structural evidence of a similar
hydrogen bond having a role in PglH. However, the observed
distance would be compatible with the formation of a hydrogen
bond if an oxygen was present instead of the methylene group. The
last step in the proposed OstA mechanism is the nucleophilic
attack from the acceptor hydroxyl to the sp2 anomeric carbon of a
short-lived oxocarbenium intermediate. We observed the C4
hydroxyl of the acceptor GalNAc positioned at ~2.7 Å from the
anomeric carbon of UDP-CH2-GalNAc (Fig. 3b, c). Taking in
account the hydrogen bound to the sp3 anomeric carbon, this
distance would be lower than the combined van der Waals radii of
the two atoms. However, given the estimated coordinate error for
this structure (maximun-likelihood based, 0.41 Å), the real distance
might be longer. Nevertheless, our structure probably represents a
state prior to the formation, but structurally similar to the transi-
tion state of the reaction.
In various biological processes, the length of lipid-linked glycan
polymers is controlled by elongation termination. In the bio-
synthesis of the E. coli O9a antigen, glycan polymerization is
catalyzed by the mannosyltransferase WbdA, and the length of
the growing glycan chain is controlled by the C-terminal domain
of the associated WbdD protein, which adopts a coiled-coil
folding and acts as a molecular ruler40. In the biosynthesis of
bacterial lipopolysaccharide, glycan repeats are polymerized by
the integral membrane protein Wzy, and the length of the
polymer is regulated by Wzz, using an unknown mechanism41. In
contrast, PglH is not an integral transmembrane protein and does
not require an additional partner to perform the glycan counting.
Instead, it contains a ruler helix that also mediates its association
to the plasma membrane. This helix and its interaction with
membrane lipids has been proposed for the related GTs GumK18,
MGD119, and MurG42. For PimA, it was shown that mutations in
a cluster of positive residues interacting with head groups of the
lipid bilayer reduced the activity in vivo, despite the fact that
in vitro binding of donor substrate was unaffected17, 25. For
successful LLO binding and GalNAc transfer, a salt bridge/
hydrogen bond interaction (3 – 4 kcal mol−1 per interaction)
between the pyrophosphate group of the LLO and the ruler helix
residues is required, and at the same time access of the terminal
GalNAc to the catalytic site of PglH. Due to the rigid, rod-shape
glycan structure43, only a penta-saccharide LLO substrate can be
ﬁt into the active site, preventing efﬁcient elongation in vivo
beyond the addition of three GalNAcs. The counting mechanism
we propose for PglH therefore depends on the interaction
between the ruler helix and the LLO substrate and the rigidity of
the glycan structure. Once released, hexa-saccharide LLO is fur-
ther modiﬁed by PglI, adding a branching glucose moiety (Fig. 5).
Once this is added, LLO binding to PglH is impossible due to
steric clashes. The counting mechanism of the processive,
membrane-associated GT PglH might be shared by other GT-B
GTs, given that there is a high structural conservation among
members of this protein family.
Methods
PglH expression and puriﬁcation. A synthetic gene encoding C. jejuni PglH
(Supplementary Methods) was cloned into a modiﬁed pET-19b vector (Novagen)
with a His10 afﬁnity tag fused to the C terminus. PglH mutants were generated by
using gBlocks gene fragments (Integrated DNA Technologies) and the resulting
plasmids of all constructs were sequenced (Microsynth). PglH wild type and
mutants were overexpressed in E. coli BL21-Gold (DE3) (Stratagene). Cells were
grown at 37 °C in modiﬁed Terriﬁc Broth (TB) medium supplemented with 1%
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glycerol (w/v) to A600 nm of 2.7 before expression was induced by the addition of
1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 16 h at 18 °C. All fol-
lowing steps were performed at 4 °C. Cells were collected by centrifugation and
resuspended in 50 mM Tris-HCl, pH 8.0; 200 mM NaCl; 3 mM β-mercaptoethanol;
3% glycerol; and 0.5 mM phenylmethanesulfonylﬂuoride (PMSF). Cell lysis was
performed in a M-110L microﬂuidizer Microﬂuidics) at 15,000 p.s.i. chamber
pressure. Membranes were pelleted by ultracentrifugation at 100,000×g for 30 min.
PglH was extracted from membranes in 50 mM Tris-HCl, pH 8.0; 200 mM
NaCl; 25 mM imidazole; 3% glycerol (v/v); 3 mM β-mercaptoethanol; 1% Triton X-
100 (w/v) by stirring for 1 h. The supernatant was loaded onto a NiNTA superﬂow
afﬁnity column (Qiagen), followed by washing with 25 column volumes with the
same buffer but containing 0.02% N-dodecyl-β-D-maltopyranoside (w/v)
(Anatrace) and 50 mM imidazole. Elution was performed in the same buffer but
containing 200 mM imidazole. The protein was desalted into 10 mM Tris-HCl, pH
8.0; 150 mM NaCl; 3% glycerol; 0.5% Polyethylene glycol 1000 (w/v); and 2 mM
dithiothreitol (DTT) and concentrated to a ﬁnal volume of 500 µL in an Amicon
Ultra-15 concentrator (Millipore) with a molecular mass cutoff of 50 kDa. The
protein was further puriﬁed by size exclusion chromatography (Superdex 200 10/
300 GL, GE Healthcare) and the buffer was exchanged to 10 mM Hepes, pH 7.5;
150 mM NaCl; 3% glycerol; 0.5% Polyethylene glycol 1000 (w/v); and 2 mM DTT.
Peak fractions were pooled and concentrated to 10–12 mgmL−1 in an Amicon
Ultra-15 concentrator (Millipore) with a molecular mass cutoff of 50 kDa.
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processed by PglI, which adds a glucose moiety to the third GalNAc
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Selenomethionine derivative production. Production of selenomethionine deri-
vative was performed as described by Perez et al.8. In brief, E. coli BL21 (DE3)
(Stratagene) expressing PglH were grown in modiﬁed TB medium supplemented
with 1% glycerol (w/v), at 37 °C to A600 nm of 0.5–1.0 and used to inoculate a
culture of M9 media supplemented with vitamin B1 hydrochloride. Cells were then
grown until A600 nm of 0.5 and used to inoculate a new culture of M9 media
supplemented with vitamin B1 hydrochloride. Cells were grown overnight at 37 °C
until A600 nm of 0.9. At that point a cocktail of amino acids (lysine, threonine,
phenylalanine, leucine, isoleucine and valine, all at 100 mg L−1) including seleno-
methionine (200 mg L−1) was added to the culture. After 30 min, expression was
induced with 1 mM IPTG for 90 min. Cells were collected by centrifugation and
preparation of membrane fraction was performed as described above.
Crystallization of PglH. For crystallization of PglH (native or the selenomethio-
nine derivative) with bound donor substrate, concentrated PglH was incubated
with UDP-GalNAc to a ﬁnal concentration of 2 mM for 15 min. Crystallization was
performed by vapor diffusion in sitting or hanging drops at 20 °C, using a reservoir
containing 0.2 M KI; 0.1 M Mops 7.2; and 17% PEG3350. The volume ratio of
protein to reservoir was 1:1.
For crystallization of PglH with bound acceptor substrate, concentrated PglH
was incubated with synthetic LLO at a ﬁnal concentration of 0.6 mM and UDP or
UDP-CH2-GalNAc at a ﬁnal concentration of 2 mM for 15 min. Crystallization was
performed by vapor diffusion in sitting drops or hanging drops at 20 °C using a
reservoir containing 0.2 M Ammonium acetate; 0.1 M ADA 6.3; and 21–22%
PEG3350. The volume ratio of protein to reservoir was 1:1.
Crystals typically appeared after 1 day and matured to full size within 3-4 days.
Crystals were cryoprotected by gently increasing the cryoprotectant concentration
in the drops (up to 30% PEG3350) and directly ﬂash frozen by immersion in liquid
nitrogen before data collection.
Data collection and structure reﬁnement. Crystals of all three structures
belonged to the space group P21. Native and selenomethionine derivative data were
collected at the beamline X06SA at the Swiss Light Source (SLS, Villigen). For PglH
bound to UDP-GalNAc, phases were solved by running Crank244 with SAD data.
The overall ﬁgure of merit was 0.82 and eight selenium sites were found in the
asymmetric unit. The initial model was built using Coot45. The structures of PglH
in complex with LLO acceptor substrate were determined by molecular replace-
ment with PglH bound to UDP-GalNAc. Two copies of PglH were found in the
asymmetric unit and noncrystallographic symmetry restraints were initially used
for the reﬁnement. For the highest-resolution structure (UDP-GalNAc), these
restraints were released in the later stages of the reﬁnement. For the lower-
resolution LLO-complexes, NCS restraints were maintained. Iterative model
building was performed in Coot45 and the X-ray structure was reﬁned in PHE-
NIX46. The ﬁnal structures of PglH/UDP-GalNAc, PglH/UDP/LLO, and PglH/
UDP-CH2-GalNAc/LLO have 96,94%, 96.28%, and 88.13% of Ramachadran
favored; 2.65%, 2.79%, and 10.20% of Ramachadran allowed; and 0.42%, 0.98%,
and 1.68% of Ramachandran outliers, respectively.
Cloning and expression and puriﬁcation of PglA and PglJ. The genes encoding
PglA and PglJ from C. jejuni (Supplementary Table 2) were cloned into a modiﬁed
pET-19b vector (Novagen) with a His10 afﬁnity tag fused to the C terminus. PglA
and PglJ were overexpressed in E. coli BL21-Gold (DE3) (Stratagene). Cells were
grown at 37 °C in modiﬁed TB medium supplemented with 1% glycerol (w/v) to
A600 nm of 2.7 before expression was induced by the addition of 1 mM isopropyl
IPTG for 3 h at 37 °C. All following steps were performed at 4 °C. Cells were
collected by centrifugation, resuspended in 50 mM Tris-HCl pH 8.0; 200 mM
NaCl; 3 mM β-mercaptoethanol; 3% glycerol; and 0.5 mM PMSF. Cell lysis was
performed in a M-110L microﬂuidizer Microﬂuidics) at 15,000 p.s.i. chamber
pressure and the cell lysate was incubated with a ﬁnal concentration of 0.5% Triton
X-100 for 1 h. Cell debris and insoluble material were pelleted by ultra-
centrifugation at 100,000×g, in Ti45i rotor, for 30 min. The supernatant was
supplemented with 25 mM imidazole and loaded onto a NiNTA superﬂow afﬁnity
column (Qiagen, Hilden, Germany), washed extensively with the same lysis buffer
but containing 50 mM imidazole and 0.05% Triton X-100. Elution was performed
in the same buffer but containing 200 mM imidazole. The proteins were desalted
into 25 mM Hepes pH 7.5; 150 mM NaCl; 5% glycerol, 2 mM DTT; and 0.05%
Triton X-100 using a HiPrep 26/10 column (GE Healthcare, Little Chalfont, UK).
Chemo-enzymatic preparation of synthetic LLO substrate. The chemical
synthesis of the LLO analog NerylNeryl-PP-GlcNAc included three steps: the
synthesis of GlcNAc α-phosphate, the preparation of the lipid phosphate pre-
cursors, and the coupling of both monophosphates to the desired ﬁnal product16.
The enzymatic addition of GalNAc units was performed in the same desalting
buffer for PglA and PglJ, but supplemented with 2 mM MgCl2. The ﬁrst reaction
catalyzed by PglA was performed incubating mM NerylNeryl-PP-GlcNAc with
UDP-GalNAc in a 4:1 molar ratio (UDP-GalNAc:LLO) and puriﬁed PglA. The
reaction product was puriﬁed by freeze drying of the reaction mixture followed by
CHCl3/MeOH (2:1, v/v) extraction. The organic phase was dried in a nitrogen
stream and the LLO products resuspended in the reaction buffer for the next
reaction. The second addition of GalNAc and the puriﬁcation of the ﬁnal product
was performed in the same way. The concentration of the ﬁnal synthetic LLO
substrate was determined by titrating different amounts of LLO against a constant
amount of the ﬂuorescently labeled acceptor peptide 5CF- GSDQNATF in an
in vitro glycosylation assay with puriﬁed PglB14.
Chemical synthesis of UDP-CH2-GalNAc. The preparation of UDP-CH2-GalNAc
was designed based on the synthesis of the C4-epimer UDP-CH2-GlcNAc30.
Several reaction conditions were optimized to achieve higher yields and purities
such as removal of the oxazoline side product by acidic treatment after the radical
allylation step, diesteriﬁcation of the hydroxy phosphonate using pyridine and 4-
dimethylaminopyridine (DMAP) as base, quick dealkylation with an excess of
TMSBr, and deacetylation with ammonium hydroxyde. Finally, puriﬁcation of the
ﬁnal product was performed by size exclusion chromatography eluted with 0.25M
NH4HCO3 buffer47, yielding UDP-CH2-GalNAc in 40 mg scale and in pure form
as conﬁrmed by nuclear magnetic resonance spectroscopy and high-resolution
mass spectrometry. Detailed reaction conditions and spectroscopic characterization
can be found in Supplementary Methods.
LLO extraction. Isolation of LLO was performed as described previously8. In brief,
LLO was extracted from E. coli SCM6 cells carrying a C. jejuni pgl cluster, con-
taining inactivated pglB and pglH genes. Lipid extraction was performed using a
mixture of methanol/chloroform (1:2), dried in a rotary evaporator, and recon-
stituted in a buffer containing 10 mM Tris, pH 8.0, 150 mM NaCl, and 1%Triton
X-100 (w/v). The concentration of reconstituted LLOs was determined as described
before.
In vitro activity assays for PglH. Reaction mixtures usually contained 1–500 nM
puriﬁed PglH protein, 20 µM LLO substrate (native or synthetic), 100 µM UDP-
GalNAc, 150 mM NaCl, 20 mM Hepes pH 7.5, 2 mM DTT, and 1% Triton X-100.
Reactions were incubated at 25 °C for 10 min and stopped by incubation for 1 min
at 75 °C. Reaction products were used as donor substrates for transfer onto a
ﬂuorescently labeled peptide using puriﬁed PglB, followed by tricine SDS-PAGE
analysis48. Fluorescent bands for peptide and glycopeptides were visualized by
using a Typhoon Trio Plus imager (GE Healthcare) with excitation set at 488 nm
and using a 526 nm SP emission ﬁlter. The amount of formed glycopeptide was
determined from band intensities of ﬂuorescence gel scans (ImageJ)14. Uncropped
scans from the gels show in Figs. 1 and 4 are shown in Supplementary Figs. 12
and 13.
For activity measurements in liposomes, these were generated using a 3:1 (w:w)
mixture of E. coli polar lipids and L-α-phosphatidilcholine (AvantiPolar Lipids)
and native tri-LLO was reconstituted8. Brieﬂy, liposomes were prepared by
extrusion through polycarbonate ﬁlters (400 nm pore size) and diluted in 10 mM
Hepes, pH 7.5, 150 mM NaCl, and 2 mM DTT. After saturation with Triton X-100,
the liposomes were mixed with native Tri-LLO. BioBeads were then added to
remove detergent. Finally, the concentration of reconstituted Tri-LLO was
determined by titrating various amounts of liposomes against a constant amount of
acceptor peptide in an in vitro glycosylation assay using puriﬁed PglB. Reaction
mixtures contained 50, 250, or 500 nM puriﬁed (wild type or mutant) PglH
protein, 1 µM LLO substrate, 10 µM UDP-GalNAc, 150 mM NaCl, 20 mM Hepes
pH 7.5, and 2 mM DTT. Reactions were incubated and the products detected as
described above for detergent-based activity assays.
For inhibition analysis, reaction mixtures containing 2 nM PglH protein, 20 µM
Und-PP-Bac-GalNAc2, 150 mM NaCl, 20 mM Hepes pH 7.5, 2 mM DTT, and 1%
Triton X-100 were incubated with different concentrations of UDP or UDP-C-
GalNAc (15 nM to 8 mM) for 5 min at 25 °C. Reactions were started with addition
of 100 µM of UDP-GalNAc. Samples were taken after 10 min. Data were ﬁtted to
non-linear regression and IC50 was determined using PRISM software.
Molecular dynamics simulations. The interaction of PglH with a lipid membrane
was studied with all-atom explicit solvent molecular dynamics (MD) simulation
using GROMACS 5.0.6.49 Initially, a bilayer of 392 palmitoyl oleoyl phosphatidyl-
ethanolamine (POPE) and 98 palmitoyl oleoyl phosphatidyl-glycerol (POPG) lipids
was created using the CHARMM-GUI webserver50. This system was solvated with
water and 150 mM NaCl, resulting in a box of ~12 × 12 × 17 nm3. After
50,000 steps of steepest descent energy minimization, the membrane patch was
simulated for 259 ns of MD simulation in the isothermal-isobaric (NPT) ensemble.
Brieﬂy, the initial systems were equilibrated for 11 ns of MD simulation in the NPT
ensemble in which all non-hydrogen atoms of the protein were restrained to the
ﬁxed reference positions with progressively smaller force constants, starting at
1000 kJ mol−1 nm2. Periodic boundary conditions were used. Particle mesh Ewald51
with cubic interpolation and 0.16 nm grid spacing for Fast Fourier Transform was
used to treat long-range electrostatic interactions. The time step was 2 fs. The
LINCS algorithm52 was used to ﬁx all bond lengths. Constant temperature (310 K)
was set with a Nose–Hoover thermostat53, with a coupling constant of 0.5 ps. A
semiisotropic Parrinello–Rahman barostat54 was used to maintain a pressure
of 1 bar
The ﬁnal structure of the lipid membrane simulation was used as starting point
for PglH-membrane docking simulations. PglH bound to UDP-GalNAc (PDB ID
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6EJI) was placed 1 nm away from the membrane. Ten random PglH orientations
were created using rigid-body rotation. Each of these conﬁgurations was initially
equilibrated for 10 ns. Restraints on non-hydrogen atoms of the protein were
gradually released, starting from 1000 kJ mol-1 nm2. Then, 90 ns of MD was
performed for each setup. Four of the runs, in which PglH had approached the
membrane, were extended to 150 ns. Of these, the two runs showing protein-
membrane interactions were extended further for a total of 250 ns each. In one
simulation, PglH docked tightly into the membrane surface.
For the simulation of PglH bound to UDP and tri-LLO, the structure bound to
the synthetic LLO substrate was used (PDB ID 6EJJ). The synthetic LLO was
replaced by the native Und-PP-Bac-GalNAc2. The whole complex was aligned with
the end structure from the simulation of PglH with UDP-GalNAc bound and was
placed in the same position relative to the membrane. The tail of LLO was built and
placed in the membrane. After minimization and 10 ns of equilibration, 500 ns of
unconstrained simulation were performed.
The all-atom CHARMM36 force ﬁeld was used for protein, lipids, and ions, and
TIP3P was used for water molecules55, 56. The MD trajectories were analyzed with
Visual Molecular Dynamics (VMD)57.
Data availability. Atomic coordinates and structure factors were deposited in the
RCSB Protein Data Bank (PDB) under accessions 6EJI (PglH in complex with
UDP-GalNAc), 6EJJ (PglH in complex with UDP and synthetic LLO), and 6EJK
(PglH in complex with UDP-CH2-GalNAc and synthetic LLO). The data that
support the ﬁndings of this study are available from the corresponding author
upon reasonable request.
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